Improving N-terminal protein annotation of Plasmodium species based on signal peptide prediction of orthologous proteins
© de Neto et al.; licensee BioMed Central Ltd. 2012
Received: 6 June 2012
Accepted: 31 October 2012
Published: 15 November 2012
Signal peptide is one of the most important motifs involved in protein trafficking and it ultimately influences protein function. Considering the expected functional conservation among orthologs it was hypothesized that divergence in signal peptides within orthologous groups is mainly due to N-terminal protein sequence misannotation. Thus, discrepancies in signal peptide prediction of orthologous proteins were used to identify misannotated proteins in five Plasmodium species.
Signal peptide (SignalP) and orthology (OrthoMCL) were combined in an innovative strategy to identify orthologous groups showing discrepancies in signal peptide prediction among their protein members (Mixed groups). In a comparative analysis, multiple alignments for each of these groups and gene models were visually inspected in search of misannotated proteins and, whenever possible, alternative gene models were proposed. Thresholds for signal peptide prediction parameters were also modified to reduce their impact as a possible source of discrepancy among orthologs. Validation of new gene models was based on RT-PCR (few examples) or on experimental evidence already published (ApiLoc).
The rate of misannotated proteins was significantly higher in Mixed groups than in Positive or Negative groups, corroborating the proposed hypothesis. A total of 478 proteins were reannotated and change of signal peptide prediction from negative to positive was the most common. Reannotations triggered the conversion of almost 50% of all Mixed groups, which were further reduced by optimization of signal peptide prediction parameters.
The methodological novelty proposed here combining orthology and signal peptide prediction proved to be an effective strategy for the identification of proteins showing wrongly N-terminal annotated sequences, and it might have an important impact in the available data for genome-wide searching of potential vaccine and drug targets and proteins involved in host/parasite interactions, as demonstrated for five Plasmodium species.
KeywordsSignal peptide Orthologous Gene annotation Malaria Plasmodium
Malaria is the most devastating parasitic disease in the world. The disease affects more than 216 million people and kills nearly 655,000 people every year . More than forty percent of the world’s population lives at risk of infection . Parasite resistance to available chemotherapy drugs and also vector resistance to insecticides are increasing and spreading around the world, which impacts disease control [3, 4]. The persistent huge socioeconomic impact of the disease and reports of resurgence in African countries show that, despite the control efforts, malaria is still a global health challenge . Hence, new strategies to control malaria are essential to combat, eliminate or even eradicate the disease .
In recent years, the sequencing of genomes, transcriptomes and proteomes and their related high-throughput analyses have become major strategies for unraveling the detailed aspects of Plasmodium biology and the interactions between the parasite and its vertebrate and invertebrate hosts [7, 8]. Genome sequence data is available for at least eight Plasmodium species, providing opportunities for many groups to join the renaissance in malaria research and translate this massive amount of data into commercially available new drugs and anti-malarial vaccines, which are still promises of the genomic era [3, 9].
The first step in genome-wide identification of new drug targets or vaccine candidates is mainly based on identification of molecules in the interface between parasite and hosts or members of unique biochemical pathways in the parasite through in silico strategies, and these analyses are highly dependent on the accuracy of genome annotations. Massive-scale sequencing has considerably improved the annotation strategies, particularly the process of identifying coding sequences (CDS) . However, gene annotation is still far from trivial, especially in eukaryotic genomes, and one of the most difficult tasks is the identification of the initial methionine and intron/exons boundaries .
Homology reflects the evolutionary history of genes and, after the recent expansion of genomics, has reemerged as one of the key concepts of evolutionary biology. Orthologs are genes derived from a single ancestral gene in the last common ancestor of the species being compared, whereas paralogs are genes related via duplication events . Orthology is the basis of any comparative genetic analysis, because orthologs tend to retain equivalent molecular and biological functions , justifying its use in interspecific comparative analyses to assist in gene annotation, by exploring evolutionary gene histories, conservation, variability of molecular sequences and functional characterizations .
Protein trafficking is essential for all organisms and this process is primarily governed by intrinsic signals found in protein sequences. The best-known and studied transport motif is the signal peptide, usually located in the N-terminal end of proteins that are translocated across the plasma membrane (prokaryotes) or the endoplasmic reticulum membrane (eukaryotes) [15–17]. Signal peptides play an indirect role on the biological function of proteins in the sense that they help determine the subcellular environment a given protein will be available for interactions . Since function is usually conserved among orthologous proteins, it was hypothesized that subcellular localization and, consequently, signal peptide status are expected to behave accordingly. Divergences among orthologs could be explained by (i) misannotation of protein sequences; (ii) limitations of the methodologies used to predict signal peptides or to assign orthology relationships; or (iii) true biological divergence resulting from singular evolutionary history of that gene in each species.
In order to study the source of divergences among Plasmodium proteins, an innovative yet computationally simple strategy was devised, in which signal peptide predictions and orthology were combined. This strategy helped to determine the prevalence of N-terminal sequence misannotations among Plasmodium proteins and, more importantly, it guided the process of revision of misannotated proteins, therefore improving the available information on protein sorting for the genus.
Combining orthology and signal peptide prediction: classification and selection of orthologous groups
Amino acid sequences for all predicted proteins from Plasmodium vivax, Plasmodium knowlesi, Plasmodium falciparum, Plasmodium berghei and Plasmodium yoelii were obtained from PlasmoDB (version 7.1)  along with information on their clustering within orthologous groups, according to OrthoMCL (version 4) . Plasmodium chabaudi sequences were not included in this study due to systematic annotation inconsistencies in its dataset from PlasmoDB (version 7.1). Protein sequences were then submitted to signal peptide prediction using SignalP 3.0  following the default settings from PlasmoDB. SignalP 3.0 employs two methods for the prediction of signal peptides, SignalP-NN and SignalP-HMM. The former runs two artificial Neural Networks and outputs five scores (S-score, C-score, Y-score, Mean-S and D-score) that vary gradually from 0 to 1 and have different thresholds. The D-score was proven to be the best discriminating parameter for SP prediction. SignalP-HMM uses a Hidden Markov Model and also gives out a score, termed Signal peptide probability (HMM probability), which also varies from 0 to 1. During a run of SignalP 3.0, SignalP-NN and SignalP-HMM can be used either concurrently or separately. Standard settings for SignalP 3.0 state that a given protein is positive if its D-score or its HMM probability are equal or higher than 0.43 and 0.5, respectively. However, the criteria for considering a positive prediction in PlasmoDB are different from the software's stand-alone version. In the default configurations of PlasmoDB, both D-score and HMM probability were kept as single parameters with thresholds of 0.5 and a third parameter was set by combining the remaining four scores (S-score, C-score, Y-score, Mean-S) from SignalP-NN. Each of the four scores was given a value of 1, if its threshold was met or 0 otherwise, the third parameter is the sum of values from each of the four scores, therefore varying from 0 to 4 in a unitary scale, and its preset threshold is 3. In PlasmoDB, a signal peptide prediction is considered positive if any of the three parameters is above the established cutoffs. By default SignalP 3.0 only considers the 70 amino acids on the N-terminal end of proteins for predicting signal peptides.
Orthology information (from OrthoMCLDB version 4), extracted from PlasmoDB (version 7.1), was used to cluster proteins into their respective orthologous groups. Signal peptide predictions (negative/positive) were analysed within orthologous groups and were used to classify groups into three classes: (i) Positive groups, in which all proteins have a positive signal peptide prediction; (ii) Negative groups, in which all proteins have negative signal peptide predictions; and (iii) Mixed groups, those presenting a mosaic of positive and negative signal peptide predictions among orthologous proteins. Groups containing two or more proteins from the same species (paralogous proteins) were excluded from inspection and reannotation (see Discussion section).
Inspection of orthologous groups and reannotation of proteins
Each orthologous group was submitted to multiple global alignments of their proteins by MAFFT (version 6.717b) using default parameters . Alignments for all Mixed groups were visualized using Jalview (version 2.6.1)  and manually inspected in search of putatively misannotations in protein sequences. Inspection was directed at the N-terminal end of proteins, approximately the first 100 amino acids, since SignalP was set to analyse the first 70 amino acids. A protein was considered putatively misannotated and was selected for reannotation when sequence inconsistencies (missing or protruding stretches of amino acids) or a clear lack of sequence conservation restricted to one or few proteins were observed, after comparative analyses among orthologs (see examples in Additional file 1). Nucleotide coding sequences, their upstream flanking regions and the coordinates for their original gene models were obtained, from PlasmoDB (version 7.1), for each selected protein and its orthologs as well. The original gene models were projected onto these nucleotide sequences and analysed with the Artemis software (release 12.0) . Several features of the gene models such as number and size of exons, conservation of exon/intron junctions, and relative position of putative initial methionine to neighboring landmarks were subjected to a comparative analysis. Whenever possible, an alternative gene model, featuring the proposed exon boundaries of the CDS of reannotated protein, was proposed. It is important to note that signal peptide predictions were only used to classify groups, but were not used to guide the selection of which proteins should be reannotated, these were chosen based exclusively on manual inspections of multiple alignments.
After complete inspection (alignment and gene models) of all Mixed groups, they were further separated into three categories: (i) No Misannotations, where visual inspection did not detect any protein sequence that needed reannotation (Additional file 1); (ii) Containing Putative Misannotations, where at least one putatively misannotated protein was identified; (iii) Inconclusive, where visual inspection was insufficient to detect which protein would most likely be prone to reannotation. Groups Containing Putative Misannotations were further divided into two subcategories: (i) Reannotated, where all detected misannotations were revised (Additional file 1); (ii) Partially reannotated, where at least one of the putatively misannotated proteins could not be reannotated.
The error rate for Mixed groups was calculated as the number of Reannotated groups (331) divided by the sum of Reannotated plus No misannotations (442). To calculate the error rates on Positive and Negative groups, randomly chosen subsets of 169 and 291 groups, respectively, were selected and manually inspected to identify misannotated proteins. Inspection was carried out following the same criteria set for Mixed groups, however, proteins were only marked for reannotation but new gene models were not proposed. The Chi-square test was performed for differences among proportions, followed by the Marascuilo procedure for pairwise comparison of proportions (Stat Tools) . Confidence Intervals (c.i. 95%) were calculated taking into consideration the total number of groups in each class before reannotations, 398 Positive, 3380 Negative and 541 Mixed.
Search for optimized signal peptide prediction parameters
Different combinations of thresholds for signal peptide prediction parameters were tested and the total numbers of Negative, Positive and Mixed groups were registered at each combination. Groups containing multiple proteins per species were also considered for this analysis, and were counted as well. First, for a broad view of the entire prediction space, D-score and HMM probability values were set to start at 0.05 and were raised to 1.0 (maximum) by adding 0.05 at each iteration, while NN-Sum was tested at 1, 2, 3 and 4. Once the region with the lowest values was identified, a new round of combinations with a shorter range was run, with D-score and HMM probability values varying by 0.01, and the NN-Sum set at its optimal threshold. The combination yielding the lowest number of Mixed groups was chosen as the optimized set of parameters and its impact on orthologous groups was measured by determining their resulting reclassifications. Twenty-six Negative and Positive groups that changed their classification to Mixed after optimization were inspected in search of putative misannotated proteins.
Functional annotation of revised genes
The ApiLoc database  was queried for published data on experimental localization of Plasmodium proteins. ApiLoc uses a structured vocabulary to describe protein subcellular localization in apicomplexan parasites. Descriptive labels were obtained for each reannotated protein and/or their respective orthologs, whenever available in ApiLoc, and were analysed in respect to which signal peptide prediction outcome would be expected for each of these proteins. The Blast2go Description Annotator (BDA) algorithm, available in the Blast2go suite (default settings: e-value cutoff of 1.0E-3, HSP length cutoff 33, nr database) , was used to recover the best possible description for all reannotated proteins.
Samples, RNA extraction and cDNA synthesis
A blood sample (5 mL) was collected from a patient in the University Hospital Julio Muller in Cuiabá, MT, after the acute infection with P. vivax was confirmed by microscopy and written consent was given. The patient was treated according to the guidelines from the Brazilian Ministry of Health , and the blood sample was stored in RNALater (Invitrogen). After removal of RNALater by centrifugation the sample at 16,000 x g for 10 minutes, RNA extraction was carried out with TRIZOL reagent (Invitrogen) following the manufacturer's instructions. RNA was treated with RQ1 DNAse (Promega) and submitted to cDNA synthesis using the ImProm-II Reverse Transcription system (Promega) for efficient synthesis of full-length cDNAs, since amplifications were targeted to the 5' end of transcripts. To identify putative genomic DNA contamination each sample was also performed in the absence of reverse transcriptase.
Validation of new gene models by RT-PCR
Seven reannotated proteins from P. vivax were selected for experimental validation of the proposed new gene models in detriment of original models. The main criterion for gene selection was that during reannotation the number of exons must have been altered, so that the different exon/intron junctions could be explored in the design of primers for RT-PCRs. For each gene, three forward (Control, Before and After) primers and one reverse primer were designed using Primer-BLAST  forming three pairs (Additional file 2). One of the pairs would amplify only if the original gene model were correct (Before), whereas another pair would only work in case the proposed new model was a better fit (After). The third pair was a positive control and would work on both situations. Whenever possible, the primers were designed to generate different sized fragments when amplified from genomic DNA or cDNA to avoid misinterpretation of results due to DNA contamination of RNA samples. Detailed amplification settings for each gene are in Additional file 2.
The Chi-square test was used for assessing the statistical significance of differences between two proportions. For more than two proportions, the Chi-square was followed by the Marascuilo procedure to analyse differences between each pair of proportions. The level of significance (α) for the analyses was 0.05.
Groups showing diverging signal peptide predictions present a higher rate of sequence misannotations
Putatively misannotated proteins were identified through the visual inspection of multiple alignments of orthologs, searching for protruding or missing N-terminus that could possibly be adjusted by selecting an alternative initiation codon. Inspection of subsets from the three classes above demonstrated that the rate of groups containing at least one misannotated protein was significantly higher in Mixed groups (78.8%) than in Positive (14.2%) and Negative groups (33.7%) (Figure 2C).
The majority of proposed new gene models have altered signal peptide predictions
Multiple alignments of proteins from each of the 541 Mixed groups were carefully manually inspected and sorted into three categories: (i) No misannotations (111 groups in Figure 1C), in which the N-terminal sequences of all proteins appear to be properly annotated (Additional file 1); (ii) Containing putative misannotations (413 groups), in which 561 putatively misannotated proteins were identified (Figure 1C); (iii) Inconclusive (17 groups in Figure 1C), for which visual inspection was insufficient to determine the annotation status of one or more proteins. The 413 groups that Containing putative misannotations were further divided into two subcategories: (i) Reannotated (331 groups in Figure 1C), in which all proteins identified as being misannotated were revised (Additional file 1); (ii) Partially reannotated (82 groups in Figure 1C), in which at least one putatively misannotated protein from each group could not be modified. From the 561 proteins initially selected for manual correction, 83 could not have a new gene model proposed (orange numbers in curly brackets in Figure 1D). For most of them it was because of missing sequence information in the upstream flanking region of the gene due to incomplete genome assembly and in one case there was a frame shift in the middle of an exon, interpreted as a possible sequencing error that prevented the reannotation. Some of the groups Partially reannotated presented some proteins that were reannotated (in addition to those that were only marked), thus, six of these groups were reclassified as negative even though groups were not fully reannotated (Figure 1D). A total of 478 proteins had their gene models revised and their amino acid sequences reannotated (green numbers in square brackets in Figure 1D).
Signal peptide predictions of proteins from Plasmodium species after reannotations
Signal peptide prediction of reannotated proteins
Total proteins with positive signal peptide predictions
Af – Bf (%)
Plasmodium yoelii followed by P. vivax were the two species presenting highest numbers of reannotated proteins, 208 and 158, respectively (Table 1). This might reflect the overall annotation status of genomes from these species when compared to others more extensively studied such as P. berghei and P. falciparum. Apart from P. berghei, all the other four species showed, as a net result, an increased number of positively predicted proteins, especially P. vivax and P. yoelii, which had over 80 proteins added to their previous counts of proteins featuring signal peptides. Proportionately, P. vivax was the species that showed the highest impact from reannotations in its final count of positively predicted proteins (Table 1). The complete list of reannotated proteins, with their new proposed sequences is available (Additional file 3).
Reannotations alter the classification of groups
Transcripts expression supports the new gene models
Reannotated proteins have functional annotation support
Reannotated proteins with direct experimental validation of subcellular localization
PlasmoDB Gene ID
Signal peptide prediction
Cytosol and food vacuole during trophozoite
Cytoplasm during gametocyte stage v
Rhoptry during schizont
Apical and basal and not nucleus during salivary gland sporozoite
Microneme during sporozoite
Apicoplast during hepatocyte schizont and salivary gland sporozoite
Apical and not surface during salivary gland sporozoite
Apical during oocyst, sporozoite
In addition, there are 57 reannotated proteins whose orthologs have experimental evidence of cellular localization (Additional file 4). For 40 of these proteins, final SP predictions were positive and, impressively, 39 (98%) of them have orthologs whose localizations concur with the presence of a signal peptide. [PlasmoDB:PVX_117660] (serine hydroxymethyltransferase) is the only reannotated protein whose positive SP prediction clearly conflicts with the experimental validation of its ortholog [PlasmoDB:PF14_0534], which does not have a signal peptide and localizes to the mitochondrion. Of the 17 reannotated proteins with negative SP predictions and experimentally validated localization of orthologs, only 8 show experimental data agreeing with an absent signal peptide. However, 5 out of the 9 remaining proteins already had negative predictions before reannotation. Also, SP predictions are negative for the orthologs of 8 out of these 9 proteins as well, despite their experimental localizations suggesting the presence of signal peptides (Additional file 4).
Gene product descriptions were also considered as hints on putative biological functions. However, approximately 60% of reannotated proteins are described as unknown or hypothetical according to PlasmoDB (v7.1). Thus, protein description was complemented by running the Blast2go Description Annotator (BDA) and hypothetical/unknown proteins were reduced to approximately 35% only (Additional file 3). After that, the focus of the functional analysis on P. vivax proteins was in the relevancy of proposed reannotations and how they may contribute in efforts to control malaria. In addition to the above mentioned experimental evidences involving P. vivax proteins, the level of agreement between reannotation outcome and product description for all reannotated proteins in this species was analysed. Out of 158 reannotated proteins, 53 are described as hypothetical or unknown and could not be analysed. Out of the remaining 105 proteins, product descriptions accorded with signal peptide predictions (after reannotation) for 78, disagreed for 15 and were considered inconclusive (insufficient descriptive information) for 12 proteins (Additional file 3).
Plasmodium falciparum orthologs supporting signal peptide predictions of Plasmodium vivax reannotated proteins
P. falciparum ortholog
P. vivax ortholog
PlasmoDB Gene ID
PlasmoDB Gene ID
Proline tRNA synthetase
Asparagine tRNA synthetase
Methionine tRNA synthetase
Leucine tRNA synthetase
Glutamate tRNA amidotransferase subunit A
DNA gyrase subunit A
DNA gyrase subunit B
Mixed groups can be further reduced by optimization of signal peptide prediction parameters
Number of orthologous groups in signal peptide group classes after optimization of signal peptide prediction parameters
Signal peptide patterns mirroring the phylogeny of Plasmodium are more common in groups consistently classified as Mixed
The approach intended in this work shifts the perception of signal peptide data as an exclusive property of individual proteins to a perspective where it also becomes a descriptive characteristic of orthologous groups of proteins, with groups being classified into three distinct categories: Positive, Negative or Mixed. It is important to note that paralogs, in general, evolve diverging functions more rapidly and more often than orthologs [12, 30]. Therefore, the expected conservation of signal peptide predictions among orthologs does not necessarily hold true for paralogs, as demonstrated for P. vivax VIR protein family . Even though OrthoMCL will only cluster recent paralogs , groups containing multiple proteins per species were excluded from the reannotation analyses. This was done because, generally, paralogs are not as conserved as orthologs in function and, consequently, in signal peptide state, according to the ortholog conjecture . The ortholog conjecture is the paradigm behind the widespread use of orthology in comparative biology, however, it has always been a rather theoretical proposition, and only recently it was put to the test. Some studies have contested its validity, especially for the direct link made between function and sequence similarity. In one particular study, paralogs were shown to be better predictors of function than orthologs . On the other hand, the ortholog conjecture has been reaffirmed by other studies that showed significantly more conservation of protein structure and expression profiles among orthologs than paralogs . These recent studies clearly signal that the debate is still open. The conservation of signal peptides has not been addressed directly until now.
The strategy was applied to the predicted protein sets of five Plasmodium species and found that an expressive number of proteins showed diverging signal peptide predictions when compared to their orthologs. The rate of Mixed groups observed was higher than expected, considering the rarity of divergence and the close evolutionary proximity of the species studied (same genus). Therefore, a few probable explanations were considered: (i) Misannotated proteins, particularly their N-terminal end; (ii) Errors or shortcomings in the predicting programs; and (iii) Biological diversity due to divergence in the course of evolution, which constituted the real Mixed groups.
Misannotated sequences were the most likely source of diverging signal peptide predictions. It is known that definition of initial methionine is the most challenging tasks for gene annotating algorithms, particularly for eukaryotes, which means that annotation of the N-terminal end of proteins, exactly where most signal peptides are found, is intrinsically less accurate . The majority of Mixed groups had at least one protein that needed N-terminal sequence reannotation. Comparing Positive and Negative groups, the rate of misannotated proteins in Mixed groups is much higher, signaling that the combinatory strategy was efficient for enrichment of misannotated sequences, a desirable trait in a quality control mechanism for sequence accuracy in genomic scale.
Most protein reannotations resulted in altered signal peptide predictions, which in turn were converted into the reclassification of orthologous groups. The new distribution of Positive, Mixed and Negative groups demonstrates that having orthologs drastically diverging in their putative subcellular targeting is far less usual than previously shown, and this erroneous interpretation was mostly due to sequence misannotation. The observed reduction of Mixed groups from 541 to 289 due to reannotation is, indeed, a conservative estimate as additional reannotations are still a possibility for the 17 Inconclusive groups and the 82 groups Partially reannotated, in which there are proteins that could not be reannotated at this moment. Therefore, the eventual correction of these groups could result in an even lower rate of Mixed groups.
The main reason preventing the reannotation of proteins from groups Partially reannotated was the truncation of the upstream flanking region. This is directly related to the assembly states of genomes and explains why P. yoelii genes were most affected. According to PlasmoDB (v7.1), among the studied species, P. yoelii has the genome with the highest count of unassigned contigs (5687), followed by P. vivax (2770). Another reflection of the assembly state of P. yoelii genome is made clear in Figure 2A, in which proteins from this species seem to be missing from several orthologous groups. Improvements in the genome assembly would likely result in the identification of these missing orthologs by gene prediction algorithms.
Sequence misannotations are more likely to generate negatively predicted proteins. Since signal peptides are defined by typical structural constrains , the probability that any randomly chosen amino acid stretch (≥ 40 amino acids), coded by a genomic sequence and having a methionine in the first position, will hold a signal peptide is lower than otherwise (data not shown). Therefore, proteins with wrongly assigned initial methionine tend to show negative signal peptide predictions. Thus, while most proteins without signal peptide will preserve their signal peptide predictions even if misannotated, most proteins with signal peptide will have their predictions inverted when misannotated. This uneven effect explains why the rate of misannotations is higher in Negative than in Positive groups and why most suggested reannotations have resulted in proteins turning from negative to positive predictions. The underlying message is that, as a rule, this particular reannotation strategy tends to increase the set of proteins predicted to have signal peptides, as demonstrated for four out of the five species studied, and this biased enrichment of positive proteins may be beneficial in the search for new vaccine targets.
In an effort to understand the persistent classification of some groups as Mixed, signal peptide prediction itself was also investigated as a source of divergence among orthologs. When combining orthology and signal peptide information, the default settings applied by PlasmoDB for signal peptide prediction were used, however, there were concerns on how well adjusted were these settings, and whether was there room for improvement. With the intention of avoiding or, at least, reducing the number of false Mixed groups created by faulty predictions, it was reasoned that optimal prediction conditions would be found when predictions among orthologs reached their highest level of agreement, minimizing the number of Mixed groups. Optimization was carried out only once, after reannotations were incorporated to the database, when ideally, parameter optimization and sequence reannotations should work to complement each other in an iterative process, with new reannotations being incorporated at each round and optimal conditions being recalculated afterwards. Therefore, the new thresholds suggested here should be considered with caution because there are still many factors that could cause further alterations (new reannotations, incorporation of new genes, changes in orthology), and should not be taken as definitive values.
Also, optimization by itself does not correct intrinsic software limitations such as a biased training dataset. Although SignalP is a robust application and has been widely employed, its eukaryotic training dataset is dominated by mammalian sequences  and it is possible that signal peptides from Plasmodium proteins are somewhat different from those of mammals. This difference alone could be responsible for overestimation of the divergence. Nonetheless, the results offer a refreshing view on how to improve signal peptide predictions within clusters of species without having to implement major changes in existing prediction softwares, and it could also contribute to the development of predictors as Mixed groups may help identify which sequences are beyond current detection limits and should, therefore, be incorporated in future training data sets.
Pre-calculated orthology clustering was chosen over an independent assessment because this information is readily available for download from PlasmoDB reflecting the resources available to the malaria community. For the same reason, PlasmoDB’s SignalP prediction settings were used instead of settings from SignalP standalone version. Also, by using pre-calculated clustering the strategy became less computationally demanding. Independent clustering could have an impact in reannotations, as groups could have been added or lost, but the major results and the overall conclusions would not change. Last, considering the evolutionary proximity of the studied species and the high conservation observed among orthologs in most groups, clustering would not vary much from that obtained from OrthoMCL.
Biological features of Plasmodium could also justify difficulties in signal peptide prediction. Some Plasmodium secretory proteins use ‘unconventional protein secretion’ which collectively describe several kinds of unusual trafficking pathways that lead to the exposure of proteins on cell surfaces or to their release into the extracellular space [37, 38]. This includes Golgi-independent trafficking of integral membrane proteins  and other variations of transport modes within the classical secretory pathway [37, 38]. In these cases, typical signal peptides are not present, and many known secreted proteins of Plasmodium are included in this category, for example, RESA, GBP-130, Pf41-2, PfHPRT, FIRA, among others . However, even for these proteins the expected conservation of signal peptide prediction state is applicable. If a given protein is trafficked via an alternative route and features a negative signal peptide prediction, the same result is to be expected from its orthologs, as they would also be subjected to the same biological processing.
Plasmodium has a very complex life cycle with multiple invasion steps mediated by highly specialized apical organelles (rhoptries, micronemes and dense granules), and targeting to these organelles is signal peptide dependent . Once invaded, red blood cells (RBCs) are remodeled by Plasmodium in a process that involves the export of several parasite proteins to the cytoplasm and membrane surface of RBCs . And again, signal peptides are required for allowing entrance into the ER and subsequent targeting to the parasitophorous vacuole (PV) lumen, the default secretory pathway for P. falciparum proteins . Biological diversity within the Plasmodium genus is also a possible explanation for Mixed orthologous groups, and the implications of divergent orthologs are rather interesting, as they are likely to be involved in processes that are unique to a few or even one organism. In Plasmodium, these genes could mediate or interfere with any of the several singular phenomena that set species apart, such as sequestration in P. falciparum, host cell invasion preferences of merozoite, variability in the maturation or morphology of gametocytes or the formation of latent stages in P. vivax. Identification of such instances, where interspecific diversity could be occurring, is of utmost relevance to malariology. However, unequivocal demonstration of biological divergence, in terms of protein localization, demands experimental procedures (i.e.: fluorescent protein tagging, immunohistochemistry with specific antibodies), which are beyond the scope of this work. Nonetheless, the likelihood of finding true biological diversity was narrowed to a subset of 141 groups that have kept their mixed classification despite efforts of reannotation and optimization. Interestingly, signal peptide prediction patterns that concur with the phylogeny of Plasmodium species were significantly over represented in these groups, which argues in favor of biological novelties as the observed divergences could then be attributed to the particular evolutionary history of each species. The proteins from these groups in particular warrant further studies to confirm or reject their link to biological phenomena restricted to subsets of Plasmodium species.
The reannotations being proposed redefine the sets of proteins that are targeted to the ER of Plasmodium organisms and are highly relevant, since protein trafficking is crucial for the successful development of these organisms within their hosts. Therefore, direct as well as indirect experimental evidences were important to support reannotations. Although validation of new gene models through RT-PCR does not allow proper identification of initial methionine, it clearly demonstrated that the new gene models are a good fit to the mRNAs being expressed by parasites, whereas original gene models were not. Only some reannotated proteins were prone to RT-PCR validation as a difference in the number of exons or a modification of exon/intron boundaries between original and new gene models are required. Apart from this prerequisite, targets for validations were chosen so both inversion and maintenance of signal peptide prediction cases were covered.
Available evidences of protein localization and their correlation to signal peptide predictions for the new protein sequences were also analysed. Although only eight have been experimentally validated, most of their localizations are in accordance to their newfound signal peptide predictions. In fact, one of them [PlasmoDB:PVX_090075], a protein localized in the rhoptries, has been characterized as a promising vaccine candidate capable of eliciting a humoral immune response and the proliferation of lymphocytes from human patients . The only conflicting protein is a male-specific protein [PlasmoDB:PFB0400w] said to be cytoplasmatic according to immunofluorescence assays, however its patchy and diffuse pattern coupled to secretory signal sequence, also identified in the manuscript, suggested that the protein may be located in cytoplasmic vesicles instead . Even when experimental evidence from orthologs were considered, signal peptide prediction of a given protein and the localization of its orthologs were highly agreeable. Out of 40 proteins with positive predictions, only one [PlasmoDB:PVX_117660] shows a signal peptide prediction incompatible with its ortholog’s localization. However, this protein shows a positive prediction, even before reannotation and it is the only protein in its orthologous group with a signal peptide, thus it remains to be experimentally demonstrated whether this P. vivax protein is indeed different from its orthologs. Among the negatively predicted proteins, concordance to orthologous localizations was lower, however, most signal peptide predictions from the orthologs themselves conflicted with their localizations. A possible explanation for contradiction between negatively predicted proteins and subcellular localization might be alternative sorting routes independent of signal peptides as discussed before.
Another challenge for signal peptide prediction in Plasmodium species is the presence of a unique organelle from apicomplexa resulting from secondary endosymbiosis, the apicoplast. This organelle is an active site of protein transcription/translation and DNA replication [47, 48]. Pharmacological and genetic perturbation of the apicoplast led to parasite death [49, 50] and it was recently described that the essential function of the apicoplast is biosynthesis of an isoprenoid precursor during the blood-stage growth. Its essentiality for the parasite survival and the absence of a metabolic counterpart in human host make the apicoplast proteins promising targets for anti-malarial drug development . As only a few proteins (~50 mostly housekeeping genes) are encoded in the organellar genome , most of apicoplast housed proteins (~500 proteins), coded in the nuclear genome, must be transported to the apicoplast, via a mechanism mediated by a bipartite sorting element formed by a signal peptide followed by a transit peptide . Several of the reannotated proteins that became positively predicted have orthologs that are apicoplast-targeted, demonstrating how these reannotation efforts may assist in the quest for new anti-malarial drugs.
The search for new intervention targets for disease control is increasingly dependent on computational approaches that query and filter vast amounts of biological data, which makes annotation accuracy a priority since imprecise inputs will return low quality results. Signal peptides, for example, are extensively employed as a filter in reverse vaccinology strategies , as targets for humoral response are usually secreted or surface attached proteins, and misinformation on protein N-terminal sequences would certainly prevent correct identification of putative targets. Most of the major Plasmodium vaccine candidates (i.e.: AMA-1, Pfs230, CS, PvDBP)  are proteins that have predicted signal peptides, demonstrating how important this feature can be in the discovery of new vaccine targets. Also, information on signal peptides can be incorporated in the process of selecting drug targets when it is known or expected that the metabolic process to suffer intervention takes place in membrane bound organelles or cellular compartments. Once more, Plasmodium stands as a good example, as it has already been demonstrated that the food vacuole  and the apicoplast  are susceptible to anti-malarial compounds, and protein targeting to both these organelles is signal peptide dependent . Apicoplast targeting was one of the filtering criteria for identifying attractive drug targets in Plasmodium falciparum in a study that used a comprehensive in silico approach .
The combinatorial strategy presented here proved to be a powerful tool for identification of misannotated N-terminal sequences, and allowed the redefinition of the list of proteins destined for ER targeting in five Plasmodium species. It might have an important impact in the available data for genome-wide searching of potential vaccine and drug targets and proteins involved in host/parasite interactions, particularly for P. vivax. Most of the proposed reannotations are already available in PlasmoDB as user comments, and the remaining set will be uploaded shortly.
This study suggests that misannotated proteins are frequently found in genome databases, reflecting limitations and shortcomings of the gene prediction algorithms used in genome annotations. Therefore, new strategies incorporating additional information, such as signal peptide prediction to these algorithms may improve the annotation process. Moreover, despite the analyses were restrained to Plasmodium species at the moment, this strategy can be readily applied to the predicted proteins of any cluster of species in order to assist in efforts to curate protein sequence information.
Hidden Markov Model
This work has a financial support of CPqRR/Programa Estruturante RIPAG. AMN, AMR, RSR, DAA and SS have scholarships from Conselho Nacional de Desenvolvimento Científico e tecnológico (CNPq) and Fundação de Amparo à Pesquisa do estado de Minas Gerais (FAPEMIG). CJFF, LHC and CFAB receive productivity fellow from CNPq.
- World Health Organization: World Malaria Report. 2011, Geneva: WHO Press
- Guerra CA, Snow RW, Hay SI: Mapping the global extent of malaria in 2005. Trends Parasitol. 2006, 22: 353-358. 10.1016/j.pt.2006.06.006.PubMed CentralView ArticlePubMed
- malERA Consultative Group on Drugs: A research agenda for malaria eradication: drugs. PLoS Med. 2011, 8: e1000402.View Article
- Raghavendra K, Barik TK, Reddy BP, Sharma P, Dash AP: Malaria vector control: from past to future. Parasitol Res. 2011, 108: 757-779. 10.1007/s00436-010-2232-0.View ArticlePubMed
- World Health Organization: World Malaria Report. 2010, Geneva: WHO Press
- Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman RD, Plowe CV, Rodriguez MH, Sinden R, Slutsker L, Tanner M: A research agenda to underpin malaria eradication. PLoS Med. 2011, 8: e1000406-10.1371/journal.pmed.1000406.PubMed CentralView ArticlePubMed
- Winzeler EA: Malaria research in the post-genomic era. Nature. 2008, 455: 751-756. 10.1038/nature07361.PubMed CentralView ArticlePubMed
- Le Roch KG, Chung DW, Ponts N: Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol. 2012, 34: 50-60. 10.1111/j.1365-3024.2011.01340.x.PubMed CentralView ArticlePubMed
- malERA Consultative Group on Vaccines: A research agenda for malaria eradication: vaccines. PLoS Med. 2011, 8: e1000398.View Article
- Reeves GA, Talavera D, Thornton JM: Genome and proteome annotation: organization, interpretation and integration. J R Soc Interface. 2009, 6: 129-147. 10.1098/rsif.2008.0341.PubMed CentralView ArticlePubMed
- Armengaud J: A perfect genome annotation is within reach with the proteomics and genomics alliance. Curr Opin Microbiol. 2009, 12: 292-300. 10.1016/j.mib.2009.03.005.View ArticlePubMed
- Koonin EV: Orthologs, paralogs, and evolutionary genomics. Annu Rev Genet. 2005, 39: 309-338. 10.1146/annurev.genet.39.073003.114725.View ArticlePubMed
- Peterson ME, Chen F, Saven JG, Roos DS, Babbitt PC, Sali A: Evolutionary constraints on structural similarity in orthologs and paralogs. Protein Sci. 2009, 18: 1306-1315. 10.1002/pro.143.PubMed CentralView ArticlePubMed
- Kristensen DM, Wolf YI, Mushegian AR, Koonin EV: Computational methods for Gene Orthology inference. Brief Bioinform. 2011, 12: 379-391. 10.1093/bib/bbr030.PubMed CentralView ArticlePubMed
- Blobel G, Dobberstein B: Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol. 1975, 67: 835-851. 10.1083/jcb.67.3.835.View ArticlePubMed
- Gierasch LM: Signal sequences. Biochemistry. 1989, 28: 923-930. 10.1021/bi00429a001.View ArticlePubMed
- Walter P, Johnson AE: Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1994, 10: 87-119. 10.1146/annurev.cb.10.110194.000511.View ArticlePubMed
- Martoglio B, Dobberstein B: Signal sequences: more than just greasy peptides. Trends Cell Biol. 1998, 8: 410-415. 10.1016/S0962-8924(98)01360-9.View ArticlePubMed
- Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, Harb OS, Heiges M, Innamorato F, Iodice J, Kissinger JC, Kraemer E, Li W, Miller JA, Nayak V, Pennington C, Pinney DF, Ross DS, Ross C, Stoeckert CJ, Treatman C, Wang H: PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009, 37: D539-D543. 10.1093/nar/gkn814.PubMed CentralView ArticlePubMed
- Li L, Stoeckert CJ, Roos DS: OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 2003, 13: 2178-2189. 10.1101/gr.1224503.PubMed CentralView ArticlePubMed
- Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004, 340: 783-795. 10.1016/j.jmb.2004.05.028.View ArticlePubMed
- Katoh K, Misawa K, Kuma K, Miyata T: MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002, 30: 3059-3066. 10.1093/nar/gkf436.PubMed CentralView ArticlePubMed
- Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ: Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009, 25: 1189-1191. 10.1093/bioinformatics/btp033.PubMed CentralView ArticlePubMed
- Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B: Artemis: sequence visualization and annotation. Bioinformatics. 2000, 16: 944-945. 10.1093/bioinformatics/16.10.944.View ArticlePubMed
- Stat Tools Home Page.http://www.stattools.net/index.php,
- ApiLoc - A database of published protein sub-cellular localisation in Apicomplexa.http://apiloc.biochem.unimelb.edu.au/apiloc/apiloc,
- Conesa A, Gotz S, Garcia-Gomez JM, Terol J, Talon M, Robles M: Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics. 2005, 21: 3674-3676. 10.1093/bioinformatics/bti610.View ArticlePubMed
- Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância epidemiológica: Guia prático de tratamento da malaria no Brasil. 2010, Brasília: Ministério da Saúde
- Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL: Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012, 13: 134-10.1186/1471-2105-13-134.PubMed CentralView ArticlePubMed
- Theissen G: Secret life of genes. Nature. 2002, 415: 741-10.1038/415741a.View ArticlePubMed
- Bernabeu M, Lopez F, Ferrer M, Martin-Jaular L, Razaname A, Corradin G, Maier A, Del Portillo H, Fernandez-Becerra C: Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol. 2012, 14: 386-400. 10.1111/j.1462-5822.2011.01726.x.View ArticlePubMed
- Dessimoz C, Gabaldon T, Roos DS, Sonnhammer E, Herrero J: Toward Community Standards in the Quest for Orthologs. Bioinformatics. 2012, 28: 900-904. 10.1093/bioinformatics/bts050.PubMed CentralView ArticlePubMed
- Nehrt NL, Clark WT, Radivojac P, Hahn MW: Testing the ortholog conjecture with comparative functional genomic data from mammals. PLoS Comput Biol. 2011, 7: e1002073-10.1371/journal.pcbi.1002073.PubMed CentralView ArticlePubMed
- McCarthy JE, Brimacombe R: Prokaryotic translation: the interactive pathway leading to initiation. Trends Genet. 1994, 10: 402-407. 10.1016/0168-9525(94)90057-4.View ArticlePubMed
- Emanuelsson O, Brunak S, von Heijne G, Nielsen H: Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc. 2007, 2: 953-971. 10.1038/nprot.2007.131.View ArticlePubMed
- Nielsen H, Brunak S, von Heijne G: Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng. 1999, 12: 3-9. 10.1093/protein/12.1.3.View ArticlePubMed
- Nickel W, Seedorf M: Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu Rev Cell Dev Biol. 2008, 24: 287-308. 10.1146/annurev.cellbio.24.110707.175320.View ArticlePubMed
- Nickel W, Rabouille C: Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol. 2009, 10: 148-155. 10.1038/nrm2617.View ArticlePubMed
- Schotman H, Karhinen L, Rabouille C: dGRASP-mediated noncanonical integrin secretion is required for Drosophila epithelial remodeling. Dev Cell. 2008, 14: 171-182. 10.1016/j.devcel.2007.12.006.View ArticlePubMed
- Lingelbach KR: Plasmodium falciparum: a molecular view of protein transport from the parasite into the host erythrocyte. Exp Parasitol. 1993, 76: 318-327. 10.1006/expr.1993.1039.View ArticlePubMed
- Kats LM, Cooke BM, Coppel RL, Black CG: Protein trafficking to apical organelles of malaria parasites - building an invasion machine. Traffic. 2008, 9: 176-186.View ArticlePubMed
- Goldberg DE, Cowman AF: Moving in and renovating: exporting proteins from Plasmodium into host erythrocytes. Nat Rev Microbiol. 2010, 8: 617-621. 10.1038/nrmicro2420.View ArticlePubMed
- Przyborski JM, Lanzer M: Protein transport and trafficking in Plasmodium falciparum-infected erythrocytes. Parasitology. 2005, 130: 373-388. 10.1017/S0031182004006729.View ArticlePubMed
- Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR: The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA. 2008, 105: 16290-16295. 10.1073/pnas.0807404105.PubMed CentralView ArticlePubMed
- Mongui A, Angel DI, Gallego G, Reyes C, Martinez P, Guhl F, Patarroyo MA: Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34). Vaccine. 2009, 28: 415-421. 10.1016/j.vaccine.2009.10.034.View ArticlePubMed
- Eksi S, Williamson KC: Male-specific expression of the paralog of malaria transmission-blocking target antigen Pfs230, PfB0400w. Mol Biochem Parasitol. 2002, 122: 127-130. 10.1016/S0166-6851(02)00091-9.View ArticlePubMed
- Dar MA, Sharma A, Mondal N, Dhar SK: Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit. Eukaryot Cell. 2007, 6: 398-412. 10.1128/EC.00357-06.PubMed CentralView ArticlePubMed
- Jackson KE, Habib S, Frugier M, Hoen R, Khan S, Pham JS: Ribas de Pouplana L, Royo M, Santos MA, Sharma A, Ralph SA: Protein translation in Plasmodium parasites. Trends Parasitol. 2011, 27: 467-476. 10.1016/j.pt.2011.05.005.View ArticlePubMed
- Fichera ME, Roos DS: A plastid organelle as a drug target in apicomplexan parasites. Nature. 1997, 390: 407-409. 10.1038/37132.View ArticlePubMed
- He CY, Shaw MK, Pletcher CH, Striepen B, Tilney LG, Roos DS: A plastid segregation defect in the protozoan parasite Toxoplasma gondii. EMBO J. 2001, 20: 330-339. 10.1093/emboj/20.3.330.PubMed CentralView ArticlePubMed
- Yeh E, DeRisi JL: Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 2011, 9: e1001138-10.1371/journal.pbio.1001138.PubMed CentralView ArticlePubMed
- Wilson RJ, Denny PW, Preiser PR, Rangachari K, Roberts K, Roy A, Whyte A, Strath M, Moore DJ, Moore PW, Williamson DH: Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J Mol Biol. 1996, 261: 155-172. 10.1006/jmbi.1996.0449.View ArticlePubMed
- van Dooren GG, Su V, D'Ombrain MC, McFadden GI: Processing of an apicoplast leader sequence in Plasmodium falciparum and the identification of a putative leader cleavage enzyme. J Biol Chem. 2002, 277: 23612-23619. 10.1074/jbc.M201748200.View ArticlePubMed
- John L, John GJ, Kholia T: A Reverse Vaccinology Approach for the Identification of Potential Vaccine Candidates from Leishmania spp. Appl Biochem Biotechnol. 2012, 167: 1340-1350. 10.1007/s12010-012-9649-0.View ArticlePubMed
- Hill AV: Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci. 2011, 366: 2806-2814. 10.1098/rstb.2011.0091.PubMed CentralView ArticlePubMed
- Egan TJ: Discovering antimalarials: a new strategy. Chem Biol. 2002, 9: 852-853. 10.1016/S1074-5521(02)00196-5.View ArticlePubMed
- Tonkin CJ, Pearce JA, McFadden GI, Cowman AF: Protein targeting to destinations of the secretory pathway in the malaria parasite Plasmodium falciparum. Curr Opin Microbiol. 2006, 9: 381-387. 10.1016/j.mib.2006.06.015.View ArticlePubMed
- Crowther GJ, Shanmugam D, Carmona SJ, Doyle MA, Hertz-Fowler C, Berriman M, Nwaka S, Ralph SA, Roos DS, Van Voorhis WC, Aguero F: Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis. 2010, 4: e804-10.1371/journal.pntd.0000804.PubMed CentralView ArticlePubMed
- Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J, Angiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, Del Portillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, Gueye AH, Guo X, Kang’a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I, White O, Ralph SA, Ren Q, Sargeant TJ, Salzberg SL, Stoeckert CJ, Sullivan SA, Yamamoto MM, Hoffman SL, Wortman JR, Gardner MJ, Galinski MR, Barnwell JW, Fraser-Liggett CM: Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008, 455: 757-763. 10.1038/nature07327.PubMed CentralView ArticlePubMed
- Olivieri A, Camarda G, Bertuccini L, van de Vegte-Bolmer M, Luty AJ, Sauerwein R, Alano P: The Plasmodium falciparum protein Pfg27 is dispensable for gametocyte and gamete production, but contributes to cell integrity during gametocytogenesis. Mol Microbiol. 2009, 73: 180-193. 10.1111/j.1365-2958.2009.06762.x.View ArticlePubMed
- Kaiser K, Matuschewski K, Camargo N, Ross J, Kappe SH: Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol Microbiol. 2004, 51: 1221-1232. 10.1046/j.1365-2958.2003.03909.x.View ArticlePubMed
- Kaiser K, Camargo N, Coppens I, Morrisey JM, Vaidya AB, Kappe SH: A member of a conserved Plasmodium protein family with membrane-attack complex/perforin (MACPF)-like domains localizes to the micronemes of sporozoites. Mol Biochem Parasitol. 2004, 133: 15-26. 10.1016/j.molbiopara.2003.08.009.View ArticlePubMed
- Pei Y, Tarun AS, Vaughan AM, Herman RW, Soliman JM, Erickson-Wayman A, Kappe SH: Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol Microbiol. 2010, 75: 957-971. 10.1111/j.1365-2958.2009.07034.x.View ArticlePubMed
- Mikolajczak SA, Silva-Rivera H, Peng X, Tarun AS, Camargo N, Jacobs-Lorena V, Daly TM, Bergman LW, de la Vega P, Williams J, Aly AS, Kappe SH: Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol Cell Biol. 2008, 28: 6196-6207. 10.1128/MCB.00553-08.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.